METTL13 and nonpapillary renal cell carcinoma: After overexpressing METTL13, the alterations in expressions of EMT-related proteins, N-cadherin and E-cadherin, were shown in (Fig. 3f), which were opposite to what resulted from siRNA disposals, indicating METTL13’s role in inhibiting EMT of ccRCC cells.